
pmid: 23522779
Magnetic resonance imaging (MRI) is the most sensitive imaging technique for assessing brainstem involvement in neurodegenerative diseases. An MRI can assess the degree of atrophy of the brainstem and alterations in signal intensity on T2-weighted images in the affected areas, which are the main imaging findings found in these diseases. Besides, diffusion-weighted MRI and proton MR spectroscopy are tools that play an important role in the characterization of these entities. Our purpose is to describe the neurodegenerative diseases that predominantly affect the brainstem highlighting the imaging findings most useful for diagnosis.
Magnetic Resonance Spectroscopy, Humans, Neurodegenerative Diseases, Neuroimaging, Protons, Magnetic Resonance Imaging, Biomarkers
Magnetic Resonance Spectroscopy, Humans, Neurodegenerative Diseases, Neuroimaging, Protons, Magnetic Resonance Imaging, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
